Basics Bioventus Inc. IPO Date: February 11, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $476.27M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 3.15% Avg Daily Range (30 D): $0.14 | 1.99% Avg Daily Range (90 D): $0.15 | 2.13% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): .3M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 189 Avg Inst. Trade: $1.43M Avg Inst. Trade (30 D): $1.5M Avg Inst. Trade (90 D): $1.75M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.68M Avg Closing Trade (30 D): $1.5M Avg Closing Trade (90 D): $2M Avg Closing Volume: 190.8K     News Aug 4, 2025 @ 12:00 PM Bioventus Enters into a New $400 Million Senior Se... Source: Dave Crawford Apr 10, 2025 @ 5:30 AM Intramedullary Nail Market size to worth USD 1,537... Source: Coherent Market Insights Nov 26, 2024 @ 4:00 PM Osteoarthritis Therapeutics Market Size to Reach U... Source: Precedence Research Oct 4, 2024 @ 9:52 AM U.S. Osteoarthritis Injectables Market Analysis 20... Source: Researchandmarkets.Com Sep 24, 2024 @ 4:23 PM First September Gains in 5 Years? Buy 3 Breakout S... Source: Zacks Financials   TTM Q2 2025 Q1 2025 Basic EPS $ $.11 $-.04 Diluted EPS $ $.11 $-.04 Revenue $ 564.14M $ 147.66M $ 123.88M Gross Profit $ 381.35M $ 102.09M $ 83.06M Net Income / Loss $ .21M $ 9.27M $ -3.32M Operating Income / Loss $ 35.3M $ 18.37M $ 4.87M Cost of Revenue $ 182.79M $ 45.57M $ 40.82M Net Cash Flow $ .92M $ 10.11M $ -18.78M PE Ratio